ACE2 News and Research

RSS
SARS-CoV-2 spike proteins can directly impact the blood-brain barrier

SARS-CoV-2 spike proteins can directly impact the blood-brain barrier

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Mouth may be primary route of SARS-CoV-2 infection and transmission

Mouth may be primary route of SARS-CoV-2 infection and transmission

A systematic review and meta-analysis of stroke in COVID-19 patients

A systematic review and meta-analysis of stroke in COVID-19 patients

Cognitive disorders associated with risk for developing severe COVID-19

Cognitive disorders associated with risk for developing severe COVID-19

Scientists compare ACE2 interaction with SARS-CoV-2 across species

Scientists compare ACE2 interaction with SARS-CoV-2 across species

Researchers demonstrate potent antibody that fights against coronavirus

Researchers demonstrate potent antibody that fights against coronavirus

Lianhuaqingwen capsule is effective for treating COVID-19 pneumonia

Lianhuaqingwen capsule is effective for treating COVID-19 pneumonia

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Gut's immune response to SARS-CoV-2 very different from the lung

Gut's immune response to SARS-CoV-2 very different from the lung

Scientists identify new therapeutic targets for SARS-CoV-2

Scientists identify new therapeutic targets for SARS-CoV-2

Lung biomarkers may predict severe COVID-19

Lung biomarkers may predict severe COVID-19

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

New peptide derivatives that target the SARS-CoV-2 spike protein

New peptide derivatives that target the SARS-CoV-2 spike protein

Transcriptomics identifies possible COVID-19 therapies

Transcriptomics identifies possible COVID-19 therapies

Study suggests 5’UTR of SARS-CoV-2 might be of pangolin coronavirus origin

Study suggests 5’UTR of SARS-CoV-2 might be of pangolin coronavirus origin

Research uncovers SARS-CoV-2 viral traits critical for the virus in human airways

Research uncovers SARS-CoV-2 viral traits critical for the virus in human airways

Small molecules block SARS-CoV-2 spike-ACE2 attachment

Small molecules block SARS-CoV-2 spike-ACE2 attachment

NRP-1 receptor potentiates SARS-CoV-2 infectivity

NRP-1 receptor potentiates SARS-CoV-2 infectivity